Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Angels of Alchemy -- Ignore unavailable to you. Want to Upgrade?

To: SirRealist who wrote (467)	5/27/2000 1:43:00 AM
From: blackmerlin	Respond to of 24256

Kevin: I am still thinking about that one. I am really not doing a lot of biotech. stock trading lately. However, I did pick up some JMAR (it has a biochips business & is also diversified enough in other areas) because I was lucky to hit a buy at 3 1/2 today. That was pretty much the bottom for this stock all week. I kind of like LGND & BTGC. BTGC is a biotech that actually has a P/E (48.68)and has recently won some major intellectual property battles with Genentech. If you like risky penny stock, ADVR may be worth investing a small amount of money in as a long-term hold or to kill boredom by playing it short-term with a buy around .32 and a sell around .40. That's all that that I can think of for now on BioMedTech stocks. Jake